Therefore, KRT17 and DHRS9 might affect the pathogenesis of COPD emphysematous phenotype by regulating tissue repair and lipid metabolism and act as phenotype-specific proteomic signatures. Here, KRT17 is linked to chronic obstructive pulmonary disease.